Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M324Revenue (TTM) $M49.8Net Margin (%)-53.1Altman Z-Score4.0
Enterprise Value $M292EPS (TTM) $-0.2Operating Margin %-53.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-52.8Higher ROA y-yY
Price/Book6.610-y EBITDA Growth Rate %-1.5Quick Ratio2.1Cash flow > EarningsY
Price/Sales6.45-y EBITDA Growth Rate %28.7Current Ratio2.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-33.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-43.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M155ROIC % (ttm)-136.2Gross Margin Increase y-yN

Gurus Latest Trades with ATRS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ATRSFirst Eagle Investment 2012-06-30 Sold Out $2.72 - $3.71
($3.13)
$ 2.09-33%Sold Out0
ATRSFirst Eagle Investment 2010-06-30 Buy $1.48 - $1.95
($1.66)
$ 2.0926%New holding20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ATRS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ATRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Powell Fred MSenior Vice President & CFO 2016-12-09Buy100,000$2.032.96view
JACOB LEONARD SDirector 2016-12-01Sell20,000$1.976.09view
GRAHAM PETER JSVP General Counsel, Secretary 2016-03-21Buy20,000$0.77171.43view
APPLE ROBERT FPresident & CEO 2016-03-18Buy60,000$0.72190.28view
GUETH ANTONDirector 2016-03-18Buy50,000$0.72190.28view
Fickenscher James ESenior Vice President & CFO 2016-03-18Buy135,000$0.72190.28view
JACOB LEONARD SDirector 2016-03-18Buy50,000$0.72190.28view
GONELLA JACQUESDirector 2016-03-18Buy100,000$0.72190.28view
GARRITY THOMAS JDirector 2016-03-18Buy30,000$0.72190.28view
SAMSON MARVINDirector 2016-03-18Buy50,000$0.72190.28view

Quarterly/Annual Reports about ATRS:

News about ATRS:

Articles On GuruFocus.com
Weekly CFO Buys Highlights Dec 13 2016 
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CFO Sells Highlight: ATRS, DENN, TTWO, JAH, ACET Jun 11 2013 

More From Other Websites
ETFs with exposure to Antares Pharma, Inc. : January 3, 2017 Jan 03 2017
Antares Pharma Announces Submission of New Drug Application for Quickshot Testosterone READ Dec 21 2016
Antares Pharma Announces Submission of New Drug Application for Quickshot® Testosterone Dec 21 2016
ANTARES PHARMA ANNOUNCES THE SUCCESSFUL COMPLETION OF TEVA’S DECENTRALIZED PROCEDURE FOR... Dec 19 2016
ETFs with exposure to Antares Pharma, Inc. : December 19, 2016 Dec 19 2016
Antares Pharma Announces the Successful Completion of Teva’s Decentralized Procedure for... Dec 19 2016
Post Earnings Coverage as Cooper Cos Revenue Climbed 14%; Non-GAAP EPS Also Added 14% Dec 16 2016
Weekly CFO Buys Highlights Dec 13 2016
Here is What Hedge Funds Think About Antares Pharma Inc (ATRS) Dec 09 2016
ETFs with exposure to Antares Pharma, Inc. : December 8, 2016 Dec 08 2016
ETFs with exposure to Antares Pharma, Inc. : November 28, 2016 Nov 28 2016
Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016 Nov 23 2016
Antares Pharma to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 23 2016
ANTARES PHARMA, INC. Financials Nov 17 2016
Antares Pharma to Present at the Jefferies 2016 Global Healthcare Conference Nov 10 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 09 2016
ANTARES PHARMA REPORTS THIRD QUARTER 2016 FINANCIAL AND OPERATING RESULTS READ Nov 09 2016
Q3 2016 Antares Pharma Inc Earnings Release - Before Market Open Nov 09 2016
Antares Pharma Reports Third Quarter 2016 Financial and Operating Results Nov 09 2016
Antares Pharma to Report Third Quarter Financial and Operating Results and Host Webcast and... Nov 04 2016
Antares Pharma to Report Third Quarter Financial and Operating Results and Host Webcast and... Nov 03 2016
Antares Pharma Announces Presentations at the Sexual Medicine Society Scientific Annual Meeting Nov 02 2016
ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Nov 01 2016
ANTARES PHARMA APPOINTS FRED M. POWELL, SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER READ Nov 01 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer Oct 31 2016
Antares Pharma Announces Multiple Presentations at the Sexual Medicine Society Scientific Annual... Oct 28 2016
ETF’s with exposure to Antares Pharma, Inc. : October 4, 2016 Oct 04 2016
Antares Pharma Announces Completion of the Quickshot Testosterone Clinical Program READ Sep 22 2016
Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and... Aug 30 2016
Antares Pharma Reports Second Quarter 2016 Operating And Financial Results READ Aug 30 2016
Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and... Aug 02 2016
TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States Jun 27 2016
Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product Jun 23 2016
Antares Pharma Announces Update to Quickshot Testosterone Program Jun 01 2016
Antares Pharma Reports First Quarter 2016 Financial and Operating Results May 09 2016
Antares Pharma to Host First Quarter Operating and Financial Results Conference Call May 05 2016
Antares Pharma to Present at the Deutsche Bank Securities,INC 41st Annual Healthcare Conference Apr 27 2016
Antares Pharma Discloses Pen 1 Development Project as Teriparatide Apr 05 2016
Antares Pharma Announces CEO Transition Jan 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)